We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

110 hedge funds and large institutions have $38.3M invested in Zomedica Corp. in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

3% more funds holding

Funds holding: 107 → 110 (+3)

1% more capital invested

Capital invested by funds: $37.8M → $38.3M (+$525K)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
110
Holders Change
+3
Holders Change %
+2.8%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
22
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$404K
2
BlackRock
BlackRock
New York
+$232K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$136K
4
HF
HRT Financial
New York
+$89.5K
5
SCA
Snowden Capital Advisors
New York
+$58.9K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$3.28M
2
N
Nuveen
North Carolina
-$349K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$337K
4
UBS AM
UBS AM
Illinois
-$251K
5
CSS
Cubist Systematic Strategies
Connecticut
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$71K -$107K -325,734 -61%
UBS Group
27
UBS Group
Switzerland
$67K +$44.2K +134,984 +208%
Teacher Retirement System of Texas
28
Teacher Retirement System of Texas
Texas
$65K +$4.16K +12,727 +7%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$63K +$23.5K +71,900 +62%
GT
30
Glenmede Trust
Pennsylvania
$60K – – –
Janus Henderson Group
31
Janus Henderson Group
United Kingdom
$60K – – –
SCA
32
Snowden Capital Advisors
New York
$60K +$58.9K +180,000 New
Millennium Management
33
Millennium Management
New York
$55K +$53.5K +163,614 New
AG
34
Algert Global
California
$44K +$42.9K +131,248 New
TSS
35
Two Sigma Securities
New York
$37K -$12.3K -37,443 -26%
GPFA
36
Game Plan Financial Advisors
Ohio
$35K – – –
EDRH
37
Edmond de Rothschild Holding
Switzerland
$34K – – –
Bank of America
38
Bank of America
North Carolina
$32K -$266 -814 -0.8%
CAN
39
Cetera Advisor Networks
California
$32K +$16 +50 +0.1%
AQR Capital Management
40
AQR Capital Management
Connecticut
$31K +$30.2K +92,407 New
WMA
41
West Michigan Advisors
Michigan
$28K +$27.5K +84,000 New
SPC
42
Sigma Planning Corp
Michigan
$27K -$4.65K -14,200 -15%
CA
43
CoreCap Advisors
Michigan
$27K -$1.18K -3,600 -4%
HSBC Holdings
44
HSBC Holdings
United Kingdom
$27K +$40 +123 +0.2%
Squarepoint
45
Squarepoint
New York
$26K +$9.88K +30,200 +66%
Citigroup
46
Citigroup
New York
$25K +$15.4K +47,018 +173%
Invesco
47
Invesco
Georgia
$24K -$3.96K -12,110 -15%
Osaic Holdings
48
Osaic Holdings
Arizona
$22K +$3.52K +10,750 +19%
ASN
49
Advisory Services Network
Georgia
$19K – – –
SOS
50
Silver Oak Securities
Tennessee
$18K +$19.2K +58,743 New
1
2
3 4 5

ZOM Hedge Fund Activity: Q1 2022 in Review

110 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2022, worth a combined $38.3M — up 1.4% from $37.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ZOM positions and 18 closed out — a net gain of 4 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $404K. The largest seller was State Street, cutting an estimated $3.28M.

  • 110 institutional investors held Zomedica Corp. (ZOM) as of Q1 2022, up from 107 in Q4 2021.
  • Funds reported $38.3M of Zomedica Corp. stock for Q1 2022, up 1.4% quarter-over-quarter.
  • 22 funds opened new Zomedica Corp. positions in Q1 2022 and 18 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q1 2022 was Citadel Advisors, an estimated $404K added.
  • The largest Zomedica Corp. seller in Q1 2022 was State Street, an estimated $3.28M sold.

Based on aggregated 13F filings for Q1 2022.